Skip to contentN
Northwest Biotherapeutics Inc
N
NWBONorthwest Biotherapeutics Inc Q1 2014 · 10-Q
Revenue$0.00$0.00−100.0% vs Q1 2013 Net Income-$46.04M-$46.04MN/M vs Q1 2013 EPS Diluted-$0.88-$0.88N/M vs Q1 2013 Operating Income-$23,682,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Northwest Biotherapeutics Inc · CIK 1072379 · Engraved from SEC EDGAR
Free Cash Flowderived-$10,559,000N/M ended Mar 31, 2014 · filed May 15, 2014 · 45 d after period end